Cargando…
Hepatic Artery Infusion of Floxuridine in Combination With Systemic Chemotherapy for Pancreatic Cancer Liver Metastasis: A Propensity Score-Matched Analysis in Two Centers
AIM: To evaluate the efficacy of hepatic artery infusion (HAI) of floxuridine (FUDR) in combination with systemic chemotherapy in patients with pancreatic cancer liver metastases (PCLM). PATIENTS AND METHODS: We retrospectively collected clinical data of 347 patients with PCLM who underwent first-li...
Autores principales: | Peng, Changli, Xu, Bin, Xiao, Juxiong, Zhou, Chunhui, Li, Xiaodong, Shi, Hongbing, Qiang, Weiguang, Wang, Tianming, Zhao, Jiemin, Liu, Fei, Li, Gang, Li, Haiping, Chen, Changyong, Shi, Liangrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113695/ https://www.ncbi.nlm.nih.gov/pubmed/33996572 http://dx.doi.org/10.3389/fonc.2021.652426 |
Ejemplares similares
-
Hepatic artery infusion pump for nasopharyngeal carcinoma with liver metastasis
por: Peng, Changli, et al.
Publicado: (2019) -
Analysis of Hepatic Artery Infusion (HAI) Chemotherapy Using Randomized Trials of Floxuridine (FUDR) for Colon Cancer Patients with Multiple Liver Metastases
por: Li, Yuanming
Publicado: (2022) -
Myosteatosis can Predict Unfavorable Outcomes in Advanced Hepatocellular Carcinoma Patients Treated With Hepatic Artery Infusion Chemotherapy and Anti-PD-1 Immunotherapy
por: Yi, Xiaoping, et al.
Publicado: (2022) -
Treatment interruptions and complications with two continuous hepatic artery floxuridine infusion systems in colorectal liver metastases.
por: Fordy, C., et al.
Publicado: (1995) -
Retracted: Analysis of Hepatic Artery Infusion (HAI) Chemotherapy Using Randomized Trials of Floxuridine (FUDR) for Colon Cancer Patients with Multiple Liver Metastases
por: Research and Practice, Gastroenterology
Publicado: (2023)